123
Participants
Start Date
May 31, 2008
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
BG9418 (Interferon beta-1a)
Avonex IM injection, self-administered per protocol
Placebo
Placebo IM injection, self-administered per protocol.
Investigator, Birmingham
Investigator, Oklahoma City
Investigator, Lakewood
Investigator, Bristol
Investigator, Wellesley Hills
Investigator, Calgary
Investigator, Kelowna
Investigator, Winnipeg
Investigator, Hradec Králové
Investigator, Ostrava
Investigator, Parbudice
Investigator, Prague
Investigator, Slaný
Investigator, Teplice
Investigator, Budapest
Investigator, Eger
Investigator, Szeged
Investigator, Székesfehérvár
Investigator, Lublin
Investigator, Pruszków
Investigator, Sopot
Investigator, Torun
Investigator, Warsaw
Investigator, Wroclaw
Investigator, Kazan'
Investigator, Krasnodar
Investigator, Lipetsk
Investigator, Moscow
Investigator, Nizhny Novgorod
Investigator, Rostov-on-Don
Investigator, Saint Petersburg
Investigator, Saratov
Investiator, Yaroslavl
Investigator, Nitra
Investigator, Trenčín
Lead Sponsor
Biogen
INDUSTRY